Biora Therapeutics, Inc. (BIOR)
USD 0.65
(9.59%)
USD 0.65
(9.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.49 Million | -64.41 Million | -167.48 Million | -165.74 Million | -106.12 Million | -65.12 Million |
| Net Income | -124.33 Million | -38.15 Million | -178.52 Million | -192.52 Million | -148.03 Million | -129.1 Million |
| Depreciation & Amortization | 555 Thousand | 907 Thousand | 1.43 Million | 5.05 Million | 6.34 Million | 6.07 Million |
| Deferred income taxes | 1.17 Million | - | 21.92 Million | 58.57 Million | - | 6.24 Million |
| Stock-based compensation | 16.47 Million | 7.8 Million | 11.96 Million | 8.24 Million | 2.37 Million | 2.26 Million |
| Change in working capital | 8.61 Million | -4.65 Million | -25.86 Million | -51.17 Million | 32.65 Million | 46.16 Million |
| Other non-cash items | 49.01 Million | -30.32 Million | 1.57 Million | 3.65 Million | 535 Thousand | 3.23 Million |
| Investing Cash Flow | 2.44 Million | -792 Thousand | -1.24 Million | -4.94 Million | 16.52 Million | 55.83 Million |
| Investments in PPE | -103 Thousand | -792 Thousand | -855 Thousand | -4.94 Million | -3.72 Million | -4.83 Million |
| Acquisitions | 11 Thousand | - | - | - | 50 Thousand | - |
| Investment purchases | - | - | - | - | -11.21 Million | -167.01 Million |
| Sales/Maturities of investments | - | - | - | - | 31.41 Million | 227.67 Million |
| Other Investing Activities | 2.53 Million | - | -387 Thousand | -1.07 Million | 20.24 Million | 60.66 Million |
| Financing Cash Flow | 30.78 Million | 7.29 Million | 165.04 Million | 229.72 Million | 73.63 Million | -12.8 Million |
| Debt repayment | -10 Million | -12 Thousand | -1.64 Million | -983 Thousand | -1.27 Million | -1.75 Million |
| Dividends payments | - | - | - | - | -4.5 Million | - |
| Common Stock Repurchased | - | 98 Thousand | - | - | - | -11.26 Million |
| Common Stock Issuance | 26.13 Million | 12.43 Million | 46.77 Million | 116.43 Million | 79.59 Million | 459 Thousand |
| Other Financing Activities | -5.35 Million | 7.31 Million | 119.91 Million | 114.27 Million | 79.41 Million | -250 Thousand |
| Accounts receivables | -2000.00 | -828 Thousand | - | 9.5 Million | 3.42 Million | 584 Thousand |
| Accounts payables | -1.17 Million | -5.07 Million | -8.68 Million | 2.85 Million | 4.38 Million | 5.77 Million |
| Inventory | - | 828 Thousand | - | -1.42 Million | -3.85 Million | -3.47 Million |
| Other working capital | 9.79 Million | 422 Thousand | -17.17 Million | -62.11 Million | 28.69 Million | 43.28 Million |
| Cash at beginning of period | 30.48 Million | 88.39 Million | 92.07 Million | 33.04 Million | 49 Million | 71.1 Million |
| Cash at end of period | 15.21 Million | 30.48 Million | 88.39 Million | 92.07 Million | 33.04 Million | 49 Million |
| Capital Expenditure | -103 Thousand | -792 Thousand | -855 Thousand | -4.94 Million | -3.72 Million | -4.83 Million |
| Effect of forex changes on cash | 2.53 Million | - | - | - | - | 9.29 Million |
| Net cash flow / Change in cash | -15.27 Million | -57.91 Million | -3.67 Million | 59.03 Million | -15.96 Million | -22.1 Million |
| Free Cash Flow | -48.6 Million | -65.2 Million | -168.34 Million | -170.68 Million | -109.84 Million | -69.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.46 Million | -4.18 Million | -124.33 Million | -15.63 Million | -73.45 Million | -17.8 Million |
| Depreciation & Amortization | 110 Thousand | 105 Thousand | 555 Thousand | 117 Thousand | 125 Thousand | 166 Thousand |
| Deferred income taxes | - | - | 1.17 Million | -3.25 Million | 48.63 Million | 161 Thousand |
| Stock-based compensation | 1.57 Million | 1.53 Million | 16.47 Million | 1.54 Million | 10.53 Million | 2.01 Million |
| Change in working capital | 3.39 Million | 2.24 Million | 8.61 Million | -799 Thousand | 2.76 Million | 3.46 Million |
| Other non-cash items | -23.07 Million | -12.26 Million | 49.01 Million | 4.27 Million | 369 Thousand | 383 Thousand |
| Investing Cash Flow | -180 Thousand | 3 Million | 2.44 Million | 2.46 Million | -1000.00 | -19 Thousand |
| Investments in PPE | -180 Thousand | -15 Thousand | -103 Thousand | -66 Thousand | -1000.00 | -20 Thousand |
| Acquisitions | - | 20 Thousand | 11 Thousand | -11 Thousand | - | 1000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 3 Million | - | - | - | - |
| Other Investing Activities | - | 20 Thousand | 2.53 Million | 2.53 Million | - | 1000.00 |
| Financing Cash Flow | 5.63 Million | 5.1 Million | 30.78 Million | 13.91 Million | -2.84 Million | 7.63 Million |
| Debt repayment | - | -2.81 Million | -10 Million | -10 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.8 Million | 2.73 Million | 26.13 Million | 5.54 Million | 181 Thousand | 7.87 Million |
| Other Financing Activities | -170 Thousand | -443 Thousand | -5.35 Million | -1.62 Million | -3.02 Million | -245 Thousand |
| Accounts receivables | - | 8000.00 | -2000.00 | -12 Thousand | - | - |
| Accounts payables | 2.37 Million | 1.8 Million | -1.17 Million | -1.45 Million | -1.15 Million | 1.62 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.02 Million | 434 Thousand | 9.79 Million | 672 Thousand | 3.91 Million | 1.84 Million |
| Cash at beginning of period | 10.82 Million | 15.21 Million | 30.48 Million | 12.56 Million | 26.45 Million | 30.46 Million |
| Cash at end of period | 5.32 Million | 10.82 Million | 15.21 Million | 15.21 Million | 12.56 Million | 26.45 Million |
| Capital Expenditure | -180 Thousand | -15 Thousand | -103 Thousand | -66 Thousand | -1000.00 | -20 Thousand |
| Effect of forex changes on cash | - | - | 2.53 Million | - | - | - |
| Net cash flow / Change in cash | -5.49 Million | -4.39 Million | -15.27 Million | 2.64 Million | -13.88 Million | -4.01 Million |
| Free Cash Flow | -11.13 Million | -12.51 Million | -48.6 Million | -13.81 Million | -11.03 Million | -11.64 Million |
UMAX
HARB-B
RDGA
GGBBF
TPIPL-R
SPKL